Hyaluronic acid-based formulations for treatment and prevention of ocular hypertension and glaucoma

An ophthalmic composition comprising hyaluronic acid and at least one active ingredient containing a prostaglandin analogue wherein the hyaluronic acid is a transporter for the prostaglandin analogue to enter the eye (transporter). The composition is for use in reducing intraocular pressure or maint...

Full description

Saved in:
Bibliographic Details
Main Author MULLER-LIERHEIM WOLFGANG GEORG KONRAD
Format Patent
LanguageChinese
English
Published 18.04.2023
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:An ophthalmic composition comprising hyaluronic acid and at least one active ingredient containing a prostaglandin analogue wherein the hyaluronic acid is a transporter for the prostaglandin analogue to enter the eye (transporter). The composition is for use in reducing intraocular pressure or maintaining reduced intraocular pressure, comprising topically applying the ophthalmic composition to the ocular surface of the eye. The composition is useful for treating, preventing, and/or delaying the onset or recurrence of ocular hypertension or glaucoma in a human subject, comprising topically applying an ophthalmic composition to the ocular surface of the eye of the subject. 一种眼用组合物，包括透明质酸和至少一种含有前列腺素类似物的活性成分，其中所述透明质酸作为前列腺素类似物进入眼睛的转运载体(转运体)。所述组合物用于降低眼内压或维持降低的眼内压，包括将该眼用组合物局部施用于眼睛的眼表面。所述组合物用于治疗、预防人类受试者的高眼压症或青光眼和/或延迟人类受试者的高眼压症或青光眼的发作或复发，包括将眼用组合物局部施用于受试者的眼睛的眼表面。
Bibliography:Application Number: CN20218051602